Academic And Community Cancer Research United

This study tests whether combining regorafenib (a drug that blocks cancer cell growth) with durvalumab (an immunotherapy that helps the immune system attack cancer) can shrink tumors in people with high-risk liver cancer. About 4 adults with advanced liver cancer that hasn't spre…

This study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 and older (or younger people who cannot take standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see how well these drugs control the cancer by helping the immune …

This study tests whether a natural supplement called PEA can reduce nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. About 88 adults who have had these symptoms for at least 3 months will take PEA or a placebo for 8 weeks. The goal is to see if PEA im…